IgG4-related disease: A systemic condition with characteristic microscopic features

Histology and Histopathology

Volumn 28, Issue 5, 2013, Pages 565-584

  Detlefsen, Sönke ^a,b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autoimmune pancreatitis; Chronic sclerosing sialadenitis; IgG4 related disease; Obliterative phlebitis; Storiform fibrosis

Indexed keywords

IMMUNOGLOBULIN G;

AUTOIMMUNE DISEASE; CHOLANGITIS; DIFFERENTIAL DIAGNOSIS; FIBROSIS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PANCREATITIS; PATHOLOGY; PHLEBITIS; REVIEW; SIALOADENITIS; THYROIDITIS;

AUTOIMMUNE DISEASES; CHOLANGITIS; DIAGNOSIS, DIFFERENTIAL; FIBROSIS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; PANCREATITIS; PHLEBITIS; SIALADENITIS; THYROIDITIS;

EID: 84877139238     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (194)

1. Albarran J. (1905). Retention renale par peri-ureterite: liberation externe de i'uretere. [In French]. Assoc. Fr. Urol. 9, 511-517.
2. Anthony P.P. (1993). Inflammatory pseudotumour (plasma cell granuloma) of lung, liver and other organs. Histopathology 23, 501-503.
3. Aoki T., Kubota K., Oka T., Hasegawa K., Hirai I. and Makuuchi M. (2003). Follicular cholangitis: another cause of benign biliary stricture. Hepatogastroenterology 50, 639-642.
4. Asada M., Nishio A., Uchida K., Kido M., Ueno S., Uza N., Kiriya K., Inoue S., Kitamura H., Ohashi S., Tamaki H., Fukui T., Matsuura M., Kawasaki K., Nishi T., Watanabe N., Nakase H., Chiba T. and Okazaki K. (2006). Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 33, 20-26.
5. Ball W.P., Baggenstoss A.H. and Bargen J.A. (1950). Pancreatic lesions associated with chronic ulcerative colitis. Arch. Pathol. (Chic.) 50, 347-358.
6. Barrett N.R. (1958). Idiopathic mediastinal fibrosis. Br. J. Surg. 46:207-218.
7. Bjornsson E., Chari S.T., Smyrk T.C. and Lindor K. (2007). Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 45, 1547-1554.
8. Chan S.K., Cheuk W., Chan K.T. and Chan J.K. (2009). IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am. J. Surg. Pathol. 33, 1249-1252.
9. Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., Zhang L., Clain J.E., Pearson R.K., Petersen B.T., Vege S.S. and Farnell M.B. (2006). Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin. Gastroenterol. Hepatol. 4, 1010-1016.
10. Chari S.T., Takahashi N., Levy M.J., Smyrk T.C., Clain J.E., Pearson R.K., Petersen B.T., Topazian M.A. and Vege S.S. (2009). A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin. Gastroenterol. Hepatol. 7, 1097-1103.
11. Chari S.T., Kloppel G., Zhang L., Notohara K., Lerch M.M. and Shimosegawa T. (2010). Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39, 549-554.
12. Chen T.S. and Montgomery E.A. (2008). Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J. Clin. Pathol. 61, 1093-1097.
13. Chetty R., Serra S., Gauchotte G., Markl B. and Agaimy A. (2011). Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cells. Pathology 43, 31-35.
14. Cheuk W. and Chan J.K. (2010). IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv. Anat. Pathol. 17, 303-332.
15. Cheuk W., Yuen H.K., Chu S.Y., Chiu E.K., Lam L.K. and Chan J.K. (2008). Lymphadenopathy of IgG4-related sclerosing disease. Am. J. Surg. Pathol. 32, 671-681.
16. Cheuk W., Chan A.C., Lam W.L., Chow S.M., Crowley P., Lloydd R., Campbell I., Thorburn M. and Chan J.K. (2009a). IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am. J. Surg. Pathol. 33, 1058-1064.
17. Cheuk W., Lee K.C., Chong L.Y., Yuen S.T. and Chan J.K. (2009b). IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am. J. Surg. Pathol. 33,1713-1719.
18. Cheuk W., Tam F.K., Chan A.N., Luk I.S., Yuen A.P., Chan W.K., Hung T.C. and Chan J.K. (2010). Idiopathic cervical fibrosis--a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am. J. Surg. Pathol. 34,1678-1685.
19. Chung H., Watanabe T., Kudo M., Maenishi O., Wakatsuki Y. and Chiba T. (2010). Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int. 30, 222-231.
20. Church N.I., Pereira S.P., Deheragoda M.G., Sandanayake N., Amin Z., Lees W.R., Gillams A., Rodriguez-Justo M., Novelli M., Seward E.W., Hatfield A.R. and Webster G.J. (2007). Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am. J. Gastroenterol. 102, 2417-2425.
21. Coffin C.M., Watterson J., Priest J.R. and Dehner L.P. (1995). Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am. J. Surg. Pathol. 19, 859-872.
22. Coffin C.M., Dehner L.P. and Meis-Kindblom J.M. (1998). Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin. Diagn. Pathol. 15, 102-110.
23. Cohen P.L., Cheek R.L., Hadler J.A., Yount W.J. and Eisenberg R.A. (1987). The subclass distribution of human IgG rheumatoid factor. J. Immunol. 139, 1466-1471.
24. Comings D.E., Skubi K.B., Van E.J. and Motulsky A.G. (1967). Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann. Intern. Med. 66, 884-892.
25. Cornell L.D., Chicano S.L., Deshpande V., Collins A.B., Selig M.K., Lauwers G.Y., Barisoni L. and Colvin R.B. (2007). Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am. J. Surg. Pathol. 31, 1586-1597.
26. Dahlgren M., Khosroshahi A., Nielsen G.P., Deshpande V. and Stone J.H. (2010). Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. (Hoboken.) 62, 1312-1318.
27. Deshpande V., Mino-Kenudson M., Brugge W. and Lauwers G.Y. (2005). Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch. Pathol. Lab. Med. 129, 1148-1154.
28. Deshpande V., Chicano S., Finkelberg D., Selig M.K., Mino-Kenudson M., Brugge W.R., Colvin R.B. and Lauwers G.Y. (2006). Autoimmune pancreatitis: a systemic immune complex mediated disease. Am. J. Surg. Pathol. 30,1537-1545.
29. Deshpande V., Gupta R., Sainani N., Sahani D.V., Virk R., Ferrone C., Khosroshahi A., Stone J.H. and Lauwers G.Y. (2011). Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am. J. Surg. Pathol. 35, 2635.
30. Deshpande V., Zen Y., Chan J.K., Yi E.E., Sato Y., Yoshino T., Kloppel G., Heathcote J.G., Khosroshahi A., Ferry J.A., Aalberse R.C., Bloch D.B., Brugge W.R., Bateman A.C., Carruthers M.N., Chari S.T., Cheuk W., Cornell L.D., Fernandez-del C.C., Forcione D.G., Hamilos D.L., Kamisawa T., Kasashima S., Kawa S., Kawano M., Lauwers G.Y., Masaki Y., Nakanuma Y., Notohara K., Okazaki K., Ryu J.K., Saeki T., Sahani D.V., Smyrk T.C., Stone J.R., Takahira M., Webster G.J., Yamamoto M., Zamboni G., Umehara H. and Stone J.H. (2012). Consensus statement on the pathology of IgG4- related disease. Mod. Pathol. 25,1181-1192.
31. Detlefsen S. and Drewes A.M. (2009). Autoimmune pancreatitis. Scand. J. Gastroenterol. 44, 1391-1407.
32. Detlefsen S., Sipos B., Zhao J., Drewes A.M. and Kloppel G. (2008). Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors. Am. J. Surg. Pathol. 32, 986-995.
33. Detlefsen S., Drewes A.M., Vyberg M. and Kloppel G. (2009). Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 454, 531-539.
34. Detlefsen S., Brasen J.H., Zamboni G., Capelli P. and Kloppel G. (2010). Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology 57, 825-835.
35. Detlefsen S., Lohr J.M., Drewes A.M., Frokjaer J.B. and Kloppel G. (2011). Current concepts in the diagnosis and treatment of type 1 and type 2 autoimmune pancreatitis. Recent Pat. Inflamm. Allergy Drug Discov. 5, 136-149.
36. Detlefsen S., Zamboni G., Frulloni L., Feyerabend B., Braun F., Gerke O., Schlitter A.M., Esposito I. and Kloppel G. (2012). Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: A study of 114 surgically treated European patients. Pancreatology 12, 276-283.
37. Ectors N., Maillet B., Aerts R., Geboes K., Donner A., Borchard F., Lankisch P., Stolte M., Luttges J., Kremer B. and Kloppel G. (1997). Non-alcoholic duct destructive chronic pancreatitis. Gut 41, 263-268.
38. Endo T., Takizawa S., Tanaka S., Takahashi M., Fujii H., Kamisawa T. and Kobayashi T. (2009). Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 58, 732-737.
39. Esposito I., Born D., Bergmann F., Longerich T., Welsch T., Giese N.A., Buchler M.W., Kleeff J., Friess H. and Schirmacher P. (2008). Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. Plos One 3, e2539.
40. Fatourechi M.M., Hay I.D., McIver B., Sebo T.J. and Fatourechi V. (2011). Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid 21, 765-772.
41. Frulloni L., Lunardi C., Simone R., Dolcino M., Scattolini C., Falconi M., Benini L., Vantini I., Corrocher R. and Puccetti A. (2009). Identification of a novel antibody associated with autoimmune pancreatitis. N. Engl. J. Med. 361, 2135-2142.
42. Fujita T., Kojima M., Gotohda N., Takahashi S., Nakagohri T., Konishi M., Ochiai A. and Kinoshita T. (2010). Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma. J. Hepatobiliary Pancreat. Sci. 17, 139-146.
43. Fukui T., Mitsuyama T., Takaoka M., Uchida K., Matsushita M. and Okazaki K. (2008). Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern. Med. 47,151-155.
44. Geyer J.T., Ferry J.A., Harris N.L., Stone J.H., Zukerberg L.R., Lauwers G.Y., Pilch B.Z. and Deshpande V. (2010). Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am. J. Surg. Pathol. 34, 202-210.
45. Ghazale A., Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., Clain J.E., Pearson R.K., Pelaez-Luna M., Petersen B.T., Vege S.S. and Farnell M.B. (2007). Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am. J. Gastroenterol. 102,1646-1653.
46. Griffin C.A., Hawkins A.L., Dvorak C., Henkle C., Ellingham T. and Perlman E.J. (1999). Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 59, 2776-2780.
47. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., Fukushima M., Nikaido T., Nakayama K., Usuda N. and Kiyosawa K. (2001). High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732-738.
48. Hamano H., Arakura N., Muraki T., Ozaki Y., Kiyosawa K. and Kawa S. (2006). Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J. Gastroenterol. 41, 11971205.
49. Harach H.R. and Williams E.D. (1983). Fibrous thyroiditis--an immunopathological study. Histopathology 7, 739-751.
50. Harrison J.D. and Rodriguez-Justo M. (2011). Commentary on IgG4- related sialadenitis: Mikulicz's disease, Kuttner's tumour, and eponymy. Histopathology 58,1164-1166.
51. Hay I.D. (1985). Thyroiditis: a clinical update. Mayo Clin. Proc. 60, 836-843.
52. Hennessey J.V. (2011). Clinical review: Riedel's thyroiditis: a clinical review. J. Clin. Endocrinol. Metab. 96, 3031-3041.
53. Himi T., Takano K., Yamamoto M., Naishiro Y. and Takahashi H. (2012). A novel concept of Mikulicz's disease as IgG4-related disease. Auris Nasus Larynx 39, 9-17.
54. Holland M., Hewins P., Goodall M., Adu D., Jefferis R. and Savage C.O. (2004). Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin. Exp. Immunol. 138, 183-192.
55. Ihrler S. and Harrison J.D. (2005). Mikulicz's disease and Mikulicz's syndrome: analysis of the original case report of 1892 in the light of current knowledge identifies a MALT lymphoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100, 334-339.
56. Imai H., Hamai K., Komatsuda A., Ohtani H. and Miura A.B. (1997). IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 51, 270-276.
57. Inoue H., Miyatani H., Sawada Y. and Yoshida Y. (2006). A case of pancreas cancer with autoimmune pancreatitis. Pancreas 33, 208209.
58. Japan Pancreas Society (2002). Diagnostic criteria for autoimmune pancreatitis. J. Jpn. Pancreas. Soc. 17, 585-587.
59. Kamisawa T., Egawa N. and Nakajima H. (2003a). Autoimmune pancreatitis is a systemic autoimmune disease. Am. J. Gastroenterol. 98, 2811-2812.
60. Kamisawa T., Funata N., Hayashi Y., Eishi Y., Koike M., Tsuruta K., Okamoto A., Egawa N. and Nakajima H. (2003b). A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 38, 982-984.
61. Kamisawa T., Funata N., Hayashi Y., Tsuruta K., Okamoto A., Amemiya K., Egawa N. and Nakajima H. (2003c). Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 52, 683687.
62. Kamisawa T., Funata N. and Hayashi Y. (2004). Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am. J. Surg. Pathol. 28, 1114.
63. Kamisawa T., Chen P.Y., Tu Y., Nakajima H., Egawa N., Tsuruta K., Okamoto A. and Hishima T. (2006a). Pancreatic cancer with a high serum IgG4 concentration. World J. Gastroenterol. 12, 6225-6228.
64. Kamisawa T., Nakajima H., Egawa N., Funata N., Tsuruta K. and Okamoto A. (2006b). IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 6,132-137.
65. Kamisawa T., Anjiki H. and Egawa N. (2009). Rapid changes in sclerosing cholangitis associated with autoimmune pancreatitis. Pancreas 38, 601-602.
66. Kamisawa T., Chari S.T., Giday S.A., Kim M.H., Chung J.B., Lee K.T., Werner J., Bergmann F., Lerch M.M., Mayerle J., Pickartz T., Lohr M., Schneider A., Frulloni L., Webster G.J., Reddy D.N., Liao W.C., Wang H.P., Okazaki K., Shimosegawa T., Kloppel G. and Go V.L. (2011). Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 40, 809-814.
67. Kasashima S., Zen Y., Kawashima A., Endo M., Matsumoto Y. and Kasashima F. (2009). A new clinicopathological entity of IgG4- related inflammatory abdominal aortic aneurysm. J. Vasc. Surg 49, 1264-1271.
68. Kashiwagi S., Kumasaka T., Bunsei N., Fukumura Y., Yamasaki S., Abe K., Mitani K., Abe H., Matsumoto T. and Suda K. (2008). Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen. Virchows Arch. 453, 275-282.
69. Katz S.M. and Vickery A.L. Jr (1974). The fibrous variant of Hashimoto's thyroiditis. Hum. Pathol. 5, 161-170.
70. Kawa S. and Hamano H. (2003). Assessment of serological markers for the diagnosis of autoimmune pancreatitis. J. Jpn. Pancreas Soc. 17, 607-610.
71. Kawa S., Kitahara K., Hamano H., Ozaki Y., Arakura N., Yoshizawa K., Umemura T., Ota M., Mizoguchi S., Shimozuru Y. and Bahram S. (2008). A novel immunoglobulin-immunoglobulin interaction in autoimmunity. Plos One 3, e1637.
72. Kawaguchi K., Koike M., Tsuruta K., Okamoto A., Tabata I. and Fujita N. (1991). Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum. Pathol. 22, 387-395.
73. Khosroshahi A. and Stone J.H. (2011). A clinical overview of IgG4- related systemic disease. Curr. Opin. Rheumatol. 23, 57-66.
74. Khosroshahi A., Bloch D.B., Deshpande V. and Stone J.H. (2010). Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 62, 1755-1762.
75. Khosroshahi A., Carruthers M.D., Deshpande V., Leb L., Reed J.I. and Stone J.H. (2011a). Cutaneous immunoglobulin G4-related systemic disease. Am. J. Med. 124, e7-e8.
76. Khosroshahi A., Deshpande V. and Stone J.H. (2011b). The clinical and pathological features of IgG(4)-related disease. Curr. Rheumatol. Rep. 13, 473-481.
77. Kim K.P., Kim M.H., Kim J.C., Lee S.S., Seo D.W. and Lee S.K. (2006). Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J. Gastroenterol. 12, 2487-2496.
78. Kino-Ohsaki J., Nishimori I., Morita M., Okazaki K., Yamamoto Y., Onishi S. and Hollingsworth M.A. (1996). Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology 110, 1579-1586.
79. Kitagawa S., Zen Y., Harada K., Sasaki M., Sato Y., Minato H., Watanabe K., Kurumaya H., Katayanagi K., Masuda S., Niwa H., Tsuneyama K., Saito K., Haratake J., Takagawa K. and Nakanuma Y. (2005). Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am. J. Surg. Pathol. 29, 783-791.
80. Kleeff J., Welsch T., Esposito I., Lohr M., Singer R., Buchler M.W. and Friess H. (2006). Autoimmune pancreatitis - a surgical disease? Chirurg 77, 154-165. (In German).
81. Kloppel G. and Adsay N.V. (2009). Chronic pancreatitis and the differential diagnosis versus pancreatic cancer. Arch. Pathol. Lab. Med. 133, 382-387.
82. Kloppel G., Detlefsen S. and Feyerabend B. (2004). Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch. 445, 1-8.
83. Kloppel G., Sipos B., Zamboni G., Kojima M. and Morohoshi T. (2007). Autoimmune pancreatitis: histo- and immunopathological features. J. Gastroenterol. 42 (Suppl 18), 28-31.
84. Kloppel G., Detlefsen S., Chari S.T., Longnecker D.S. and Zamboni G. (2010). Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J. Gastroenterol. 45, 787-793.
85. Komatsu K., Hamano H., Ochi Y., Takayama M., Muraki T., Yoshizawa K., Sakurai A., Ota M. and Kawa S. (2005). High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig. Dis. Sci. 50, 1052-1057.
86. Kroemer G., Hirsch F., Gonzalez-Garcia A. and Martinez C. (1996). Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24, 25-33.
87. Kuo T.T., Chen T.C. and Lee L.Y. (2009). Sclerosing angiomatoid nodular transformation of the spleen (SANT): clinicopathological study of 10 cases with or without abdominal disseminated calcifying fibrous tumors, and the presence of a significant number of IgG4+ plasma cells. Pathol. Int. 59, 844-850.
88. Küttner H. (1896). Über entzündliche Tumoren der Submaxillar-Speicheldrüse. Bruns. Beitr. Klin. Chir 15, 815-828. (In German).
89. Laco J., Ryska A., Celakovsky P., Dolezalova H., Mottl R. and Tucek L. (2011). Chronic sclerosing sialadenitis as one of the immunoglobulin G4-related diseases: a clinicopathological study of six cases from Central Europe. Histopathology 58,1157-1163.
90. Lee J.Y., Lim J.H. and Lim H.K. (2005). Follicular cholangitis mimicking hilar cholangiocarcinoma. Abdom. Imaging 30, 744-747.
91. Leu H.J. (1990). Inflammatory abdominal aortic aneurysms: a disease entity? Histological analysis of 60 cases of inflammatory aortic aneurysms of unknown aetiology. Virchows Arch. A 417, 427-433.
92. Li Y., Bai Y., Liu Z., Ozaki T., Taniguchi E., Mori I., Nagayama K., Nakamura H. and Kakudo K. (2009). Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol. Int. 59, 636-641.
93. Li Y., Nishihara E., Hirokawa M., Taniguchi E., Miyauchi A. and Kakudo K. (2010). Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J. Clin. Endocrinol. Metab. 95, 1309-1317.
94. Liu L.J., Chen M., Yu F., Zhao M.H. and Wang H.Y. (2008). IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology. (Carlton.) 13, 629-635.
95. Lohr J.M., Faissner R., Koczan D., Bewerunge P., Bassi C., Brors B., Eils R., Frulloni L., Funk A., Halangk W., Jesnowski R., Kaderali L., Kleeff J., Kruger B., Lerch M.M., Losel R., Magnani M., Neumaier M., Nittka S., Sahin-Toth M., Sanger J., Serafini S., Schnolzer M., Thierse H.J., Wandschneider S., Zamboni G. and Kloppel G. (2010). Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am. J. Gastroenterol. 105, 2060-2071.
96. Maire F., Le B.Y., Rebours V., Vullierme M.P., Couvelard A., Voitot H., Sauvanet A., Hentic O., Levy P., Ruszniewski P. and Hammel P. 2011. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am. J. Gastroenterol. 106, 151-156.
97. Masaki Y., Dong L., Kurose N., Kitagawa K., Morikawa Y., Yamamoto M., Takahashi H., Shinomura Y., Imai K., Saeki T., Azumi A., Nakada S., Sugiyama E., Matsui S., Origuchi T., Nishiyama S., Nishimori I., Nojima T., Yamada K., Kawano M., Zen Y., Kaneko M., Miyazaki K., Tsubota K., Eguchi K., Tomoda K., Sawaki T., Kawanami T., Tanaka M., Fukushima T., Sugai S. and Umehara H. 2009. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann. Rheum. Dis. 68, 1310-1315.
98. Mendes F. and Lindor K.D. (2010). Primary sclerosing cholangitis: overview and update. Nat. Rev. Gastroenterol. Hepatol. 7, 611-619.
99. Mendes F.D., Jorgensen R., Keach J., Katzmann J.A., Smyrk T., Donlinger J., Chari S. and Lindor K.D. (2006). Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 101, 2070-2075.
100. Mikulicz J. (1892). Ueber eine eigenartige symmetrische Erkrankung der Thranen- und Mundspeicheldrusen. In: Beitrage zur Chirurgie. Festschrift gewidmet Theodor Billroth. Stuttgart: Ferdinand Enke 610-630. (in german).
101. Motosugi U., Ichikawa T., Yamaguchi H., Nakazawa T., Katoh R., Itakura J., Fujii H., Sato T., Araki T. and Shimizu M. (2009). Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol. Int. 59, 744-747.
102. Muraki T., Hamano H., Ochi Y., Komatsu K., Komiyama Y., Arakura N., Yoshizawa K., Ota M., Kawa S. and Kiyosawa K. (2006). Autoimmune pancreatitis and complement activation system. Pancreas 32, 16-21.
103. Murata K., Fox-Talbot K., Qian Z., Takahashi K., Stahl G.L., Baldwin W.M. III and Wasowska B.A. (2007). Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants. Am. J. Transplant. 7, 2605-2614.
104. Nagai Y., Hayama N., Kishimoto T., Furuya M., Takahashi Y., Otsuka M., Miyazaki M. and Nakatani Y. (2008). Predominance of IgG4+ plasma cells and CD68 positivity in sclerosing angiomatoid nodular transformation (SANT). Histopathology 53, 495-498.
105. Naitoh I., Nakazawa T., Ohara H., Ando T., Hayashi K., Tanaka H., Okumura F., Sano H. and Joh T. (2009). IgG4-related hepatic inflammatory pseudotumor with sclerosing cholangitis: a case report and review of the literature. Cases J. 2, 7029.
106. Nakanuma Y. and Zen Y. (2007). Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol. Res. 37 (Suppl 3), S478-S486.
107. Neild G.H., Rodriguez-Justo M., Wall C. and Connolly J.O. (2006). Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 4, 23.
108. Nishi H., Tojo A., Onozato M.L., Jimbo R., Nangaku M., Uozaki H., Hirano K., Isayama H., Omata M., Kaname S. and Fujita T. (2007). Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol. Dial. Transplant. 22,1273-1275.
109. Nishi H., Shibagaki Y., Hirano K., Akahane M., Kido R., Nangaku M., Kaname S., Sasahira N., Isayama H., Tada M., Tsukamoto R., Ohtomo K., Omata M. and Fujita T. (2010). Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy response. Clin. Nephrol. 73, 253-259.
110. Nishimori I., Miyaji E., Morimoto K., Nagao K., Kamada M. and Onishi S. 2005. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54, 274-281.
111. Nishimori I., Kohsaki T., Onishi S., Shuin T., Kohsaki S., Ogawa Y., Matsumoto M., Hiroi M., Hamano H. and Kawa S. (2007). IgG4- related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern. Med. 46, 1983-1989.
112. Nomura Y., Naito Y., Eriguchi N., Kume T., Itai N., Sonoda H., Hayashida S., Naito S., Naito H., Yasumoto M., Akiba J., Kinoshita H., Yano H. and Kage M. (2011). A case of IgG4-related sclerosing mesenteritis. Pathol. Res. Pract 207, 518-521.
113. Notohara K., Burgart L.J., Yadav D., Chari S. and Smyrk T.C. (2003). Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am. J. Surg. Pathol. 27,1119-1127.
114. Ogiya A., Tanaka K., Tadokoro Y., Kikutani M., Uematsu T., Kashiwagi H., Kasami M. and Takahashi K. (2010). IgG4-related sclerosing disease of the breast successfully treated by steroid therapy. Breast Cancer. (in press).
115. Ogura K., Matsumoto T., Aoki Y., Kitabatake T., Fujisawa M. and Kojima K. (2010). IgG4-related tumour-forming mastitis with histological appearances of granulomatous lobular mastitis: comparison with other types of tumour-forming mastitis. Histopathology 57, 39-45.
116. Okazaki K., Uchida K., Ohana M., Nakase H., Uose S., Inai M., Matsushima Y., Katamura K., Ohmori K. and Chiba T. (2000). Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118, 573-581.
117. Okazaki K., Kawa S., Kamisawa T., Ito T., Inui K., Irie H., Irisawa A., Kubo K., Notohara K., Hasebe O., Fujinaga Y., Ohara H., Tanaka S., Nishino T., Nishimori I., Nishiyama T., Suda K., Shiratori K., Shimosegawa T. and Tanaka M. (2009). Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 38, 849-866.
118. Okazaki K., Uchida K., Koyabu M., Miyoshi H. and Takaoka M. (2011). Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J. Gastroenterol. 46, 277-288.
119. Ormond J.K. (1948). Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J. Urol. 59, 1072-1079.
120. Otsuki M., Chung J.B., Okazaki K., Kim M.H., Kamisawa T., Kawa S., Park S.W., Shimosegawa T., Lee K., Ito T., Nishimori I., Notohara K., Naruse S., Ko S.B. and Kihara Y. (2008). Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J. Gastroenterol. 43, 403-408.
121. Palazzo J.P. and Chang C.D. (1993). Inflammatory pseudotumour of the pancreas. Histopathology 23, 475-477.
122. Pezzilli R. and Morselli-Labate A.M. (2010). The concept of autoimmune pancreatitis and its immunological backgrounds. Expert. Rev. Clin. Immunol. 6, 125-136.
123. Plaza J.A., Garrity J.A., Dogan A., Ananthamurthy A., Witzig T.E. and Salomao D.R. (2011). Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch. Ophthalmol. 129, 421-428.
124. Raina A., Krasinskas A.M., Greer J.B., Lamb J., Fink E., Moser A.J., Zeh H.J. III, Slivka A. and Whitcomb D.C. (2008). Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch. Pathol. Lab. Med. 132, 48-53.
125. Raissian Y., Nasr S.H., Larsen C.P., Colvin R.B., Smyrk T.C., Takahashi N., Bhalodia A., Sohani A.R., Zhang L., Chari S., Sethi S.,Fidler M.E. and Cornell L.D. (2011). Diagnosis of IgG4-related tubulointerstitial nephritis. J. Am. Soc. Nephrol. 22, 1343-1352.
126. Rice D.H., Batsakis J.G. and Coulthard S.W. (1975). Sclerosing cervicitis: homologue of sclerosing retroperitonitis and mediastinitis. Arch. Surg. 110, 120-122.
127. Riedel B.M.C.L. (1896). Die chronische, zur Bildung eisenharter Tumoren fuehrende Entzuendung der Schilddruese. Verh. Dtsch. Ges. Chir. 25, 101-105. (in german).
128. Riedel B.M.C.L. (1897). Vorstellung eines Kranken mit chronischer Strumitis. Verh. Dtsch. Ges. Chir. 26, 127-129. (in german).
129. Ryu J.H., Sekiguchi H. and Yi E.S. (2012). Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur. Respir. J. 39, 180-186.
130. Saeki T., Imai N., Ito T., Yamazaki H. and Nishi S. (2009a). Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin. Nephrol. 71, 173-178.
131. Saeki T., Ito T., Yamazaki H., Imai N. and Nishi S. (2009b). Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome. Rheumatol. Int. 30, 99-103.
132. Sah R.P., Chari S.T., Pannala R., Sugumar A., Clain J.E., Levy M.J., Pearson R.K., Smyrk T.C., Petersen B.T., Topazian M.D., Takahashi N., Farnell M.B. and Vege S.S. (2010). Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 139, 140-148.
133. Sahani D.V., Kalva S.P., Farrell J., Maher M.M., Saini S., Mueller P.R., Lauwers G.Y., Fernandez C.D., Warshaw A.L. and Simeone J.F. (2004). Autoimmune pancreatitis: imaging features. Radiology 233, 345-352.
134. Sakamoto A., Nagai R., Saito K., Imai Y., Takahashi M., Hosoya Y., Takeda N., Hirano K., Koike K., Enomoto Y., Kume H., Homma Y., Maeda D., Yamada H., Fukayama M., Hirata Y. and Ishizaka N. (2012). Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis--retrospective analysis of 11 case histories. J. Cardiol. 59,139-146.
135. Sarles H., Sarles J.C., Muratore R. and Guien C. (1961). Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am. J. Dig. Dis. 6, 688-698.
136. Sato Y., Kojima M., Takata K., Morito T., Asaoku H., Takeuchi T., Mizobuchi K., Fujihara M., Kuraoka K., Nakai T., Ichimura K., Tanaka T., Tamura M., Nishikawa Y. and Yoshino T. (2009). Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod. Pathol. 22, 589-599.
137. Sato Y., Kojima M., Takata K., Huang X., Hayashi E., Manabe A., Miki Y. and Yoshino T. (2011). Immunoglobulin G4-related lymphadenopathy with inflammatory pseudotumor-like features. Med. Mol. Morphol. 44, 179-182.
138. Schrumpf E. and Boberg K.M. (2001). Epidemiology of primary sclerosing cholangitis. Best. Pract. Res. Clin. Gastroenterol. 15, 553-562.
139. Sciot R., Dal C.P., Fletcher C.D., Hernandez J.M., Garcia J.L., Samson I., Ramos L., Brys P., Van D.B. and Van den B.H. (1997). Inflammatory myofibroblastic tumor of bone: report of two cases with evidence of clonal chromosomal changes. Am. J. Surg. Pathol. 21, 1166-1172.
140. Seifert G., Miehlke A., Haubrich J., Chilla R. and Sialadenitis. (1986a). In: Diseases of the salivary glands: Pathology - diagnosis - treatment - facial nerve surgery. Georg Thieme Verlag, Stuttgart 1st ed, 110-163.
141. Seifert G., Miehlke A., Haubrich J., Chilla R. and Sialolithias. (1986b). In: Diseases of the salivary glands: Pathology - diagnosis - treatment - facial nerve surgery. 1st ed. Georg Thieme Verlag, Stuttgart, 85-90.
142. Shimatsu A., Oki Y., Fujisawa I. and Sano T. (2009). Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr. J 56, 1033-1041.
143. Shimosegawa T., Chari S.T., Frulloni L., Kamisawa T., Kawa S., Mino- Kenudson M., Kim M.H., Kloppel G., Lerch M.M., Lohr M., Notohara K., Okazaki K., Schneider A. and Zhang L. (2011). International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40, 352-358.
144. Silveira M.G. and Lindor K.D. (2008). Primary sclerosing cholangitis. Can. J. Gastroenterol. 22, 689-698.
145. Smyrk T.C. (2011). Pathological features of IgG4-related sclerosing disease. Curr. Opin. Rheumatol. 23, 74-79.
146. Stanley J.R. and Amagai M. (2006). Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N. Engl. J. Med. 355, 1800-1810.
147. Stone J.H., Khosroshahi A., Deshpande V., Chan J.K., Heathcote J.G., Aalberse R., Azumi A., Bloch D.B., Brugge W.R., Carruthers M.N., Cheuk W., Cornell L., Castillo C.F., Ferry J.A., Forcione D., Kloppel G., Hamilos D.L., Kamisawa T., Kasashima S., Kawa S., Kawano M., Masaki Y., Notohara K., Okazaki K., Ryu J.K., Saeki T., Sahani D., Sato Y., Smyrk T., Stone J.R., Takahira M., Umehara H., Webster G., Yamamoto M., Yi E., Yoshino T., Zamboni G., Zen Y. and Chari S. (2012a). Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 64, 3061-3067.
148. Stone J.H., Zen Y. and Deshpande V. (2012b). IgG4-related disease. N. Engl. J. Med. 366, 539-551.
149. Strehl J.D., Hartmann A. and Agaimy A. (2011). Numerous IgG4- positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J. Clin. Pathol. 64, 237-243.
150. Sugimoto T., Morita Y., Isshiki K., Yamamoto T., Uzu T., Kashiwagi A., Horie M. and Asai T. (2008). Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease. Int. J. Cardiol. 130, e100-e101.
151. Taguchi M., Kihara Y., Nagashio Y., Yamamoto M., Otsuki M. and Harada M. (2009). Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J. Gastroenterol. 44, 1133-1139.
152. Takahashi N., Ghazale A.H., Smyrk T.C., Mandrekar J.N. and Chari S.T. (2009). Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non- Hodgkin lymphoma. Pancreas 38, 523-526.
153. Takahira M., Kawano M., Zen Y., Minato H., Yamada K. and Sugiyama K. (2007). IgG4-Related Chronic Sclerosing Dacryoadenitis. Arch. Ophthalmol. 125, 1575-1578.
154. Takizawa S., Endo T., Wanjia X., Tanaka S., Takahashi M. and Kobayashi T. (2009). HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem. Biophys. Res. Commun. 386, 192-196.
155. Treissman S.P., Gillis D.A., Lee C.L., Giacomantonio M. and Resch L. (1994). Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer 73, 1433-1437.
156. Tubbs O.S. (1946). Superior vena caval obstruction due to chronic mediastinitis. Thorax 1:247-256.
157. Uchida K., Okazaki K., Konishi Y., Ohana M., Takakuwa H., Hajiro K. and Chiba T. (2000). Clinical analysis of autoimmune-related pancreatitis. Am. J. Gastroenterol. 95, 2788-2794.
158. Uchiyama-Tanaka Y., Mori Y., Kimura T., Sonomura K., Umemura S., Kishimoto N., Nose A., Tokoro T., Kijima Y., Yamahara H., Nagata T., Masaki H., Umeda Y., Okazaki K. and Iwasaka T. (2004). Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am. J. Kidney Dis. 43, e18-e25.
159. Uehara T., Hamano H., Kawakami M., Koyama M., Kawa S., Sano K., Honda T., Oki K. and Ota H. (2008). Autoimmune pancreatitis- associated prostatitis: distinct clinicopathological entity. Pathol. Int. 58, 118-125.
160. Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., Matsui S., Sumida T., Mimori T., Tanaka Y., Tsubota K., Yoshino T., Kawa S., Suzuki R., Takegami T., Tomosugi N., Kurose N., Ishigaki Y., Azumi A., Kojima M., Nakamura S. and Inoue D. (2012a). A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 22, 1-14.
161. Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., Matsui S., Yoshino T., Nakamura S., Kawa S., Hamano H., Kamisawa T., Shimosegawa T., Shimatsu A., Nakamura S., Ito T., Notohara K., Sumida T., Tanaka Y., Mimori T., Chiba T., Mishima M., Hibi T., Tsubouchi H., Inui K. and Ohara H. (2012b). Comprehensive diagnostic criteria for IgG4-related disease (IgG4- RD), 2011. Mod. Rheumatol. 22, 21-30.
162. Umemura T., Zen Y., Hamano H., Joshita S., Ichijo T., Yoshizawa K., Kiyosawa K., Ota M., Kawa S., Nakanuma Y. and Tanaka E. (2011). Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J. Gastroenterol. 46 Suppl 1, 48-55.
163. Umiker W.O. and Iverson L. (1954). Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J. Thorac. Surg. 28:55-63.
164. Vaglio A., Salvarani C. and Buzio C. (2006). Retroperitoneal fibrosis. Lancet 367, 241-251.
165. Vaglio A., Strehl J.D., Manger B., Maritati F., Alberici F., Beyer C., Rech J., Sinico R.A., Bonatti F., Battistelli L., Distler J.H., Schett G. and Zwerina J. (2012). IgG4 immune response in Churg-Strauss syndrome. Ann. Rheum. Dis. 71, 390-393.
166. Valdez R., Thorson J., Finn W.G., Schnitzer B. and Kleer C.G. (2003). Lymphocytic mastitis and diabetic mastopathy: a molecular, immunophenotypic, and clinicopathologic evaluation of 11 cases. Mod. Pathol 16, 223-228.
167. van der Giessen M., Homan W.L., van K.G., Aalberse R.C. and Dieges P.H. (1976). Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int. Arch. Allergy Appl. Immunol. 50, 625-640.
168. van der Neut K.M., Schuurman J., Losen M., Bleeker W.K., Martinez- Martinez P., Vermeulen E., den Bleker T.H., Wiegman L., Vink T., Aarden L.A., De Baets M.H., van de Winkel J.G., Aalberse R.C. and Parren P.W. (2007). Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317, 1554-1557.
169. van der Vliet H.J. and Perenboom R.M. (2004). Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann. Intern. Med. 141, 896-897.
170. van der Zee J.S., van S.P. and Aalberse R.C. (1986). Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J. Immunol. 137, 3566-3571.
171. Walker D.I., Bloor K., Williams G. and Gillie I. (1972). Inflammatory aneurysms of the abdominal aorta. Br. J. Surg. 59, 609-614.
172. Witkiewicz A.K., Kennedy E.P., Kennyon L., Yeo C.J. and Hruban R.H. (2008). Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum. Pathol. 39, 1548-1551.
173. Wong S., Lam W.Y., Wong W.K. and Lee K.C. (2007). Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4- related systemic disease. Hum. Pathol. 38, 1720-1723.
174. Yamamoto M., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., Takahashi H. and Imai K. (2004). Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand. J. Rheumatol. 33, 432-433.
175. Yamamoto M., Harada S., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., Takahashi H. and Imai K. (2005). Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 44, 227-234.
176. Yamamoto H., Yamaguchi H., Aishima S., Oda Y., Kohashi K., Oshiro Y. and Tsuneyoshi M. (2009). Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am. J. Surg. Pathol. 33, 1330-1340.
177. Yamamoto M., Naishiro Y., Suzuki C., Kokai Y., Suzuki R., Honda S., Abe T., Takahashi H. and Shinomura Y. (2010). Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome. Rheumatol. Int. 30, 565-568.
178. Yamamoto M., Takahashi H., Tabeya T., Suzuki C., Naishiro Y., Ishigami K., Yajima H., Shimizu Y., Obara M., Yamamoto H., Himi T., Imai K. and Shinomura Y. (2012). Risk of malignancies in IgG4- related disease. Mod. Rheumatol. 22, 414-418.
179. Yamashita K., Haga H., Mikami Y., Kanematsu A., Nakashima Y., Kotani H., Ogawa O. and Manabe T. (2008). Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology 52, 404-409.
180. Yi E. and Aubry M.C. (2010). Pulmonary pseudoneoplasms. Arch. Pathol. Lab. Med. 134, 417-426.
181. Yoshida K., Toki F., Takeuchi T., Watanabe S., Shiratori K. and Hayashi N. (1995). Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40, 1561-1568.
182. Yoshimura Y., Takeda S., Ieki Y., Takazakura E., Koizumi H. and Takagawa K. (2006). IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern. Med. 45, 897-901.
183. Zamboni G., Capelli P., Pesci A., Beghelli S., Luttges J. and Kloppel G. (2000). Pancreatic head mass: what can be done? Classification: the pathological point of view. JOP 1, 77-84.
184. Zamboni G., Lüges J., Capelli P., Frulloni L., Cavallini G., Pederzoli P., Leins A., Longnecker D. and Kloppel G. (2004). Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 445, 552-563.
185. Zamboni G., Capelli P., Scarpa A., Bogina G., Pesci A., Brunello E. and Kloppel G. (2009). Nonneoplastic mimickers of pancreatic neoplasms. Arch. Pathol. Lab. Med. 133, 439-453.
186. Zen Y. and Nakanuma Y. (2012). IgG4 Cholangiopathy. Int. J. Hepatol. 2012, 472376.
187. Zen Y., Kasahara Y., Horita K., Miyayama S., Miura S., Kitagawa S. and Nakanuma Y. (2005a). Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am. J. Surg. Pathol. 29, 275-278.
188. Zen Y., Kitagawa S., Minato H., Kurumaya H., Katayanagi K., Masuda S., Niwa H., Fujimura M. and Nakanuma Y. (2005b). IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum. Pathol 36, 710-717.
189. Zen Y., Fujii T., Harada K., Kawano M., Yamada K., Takahira M. and Nakanuma Y. (2007a). Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45, 1538-1546.
190. Zen Y., Fujii T., Sato Y., Masuda S. and Nakanuma Y. (2007b). Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod. Pathol. 20, 884-894.
191. Zen Y., Inoue D., Kitao A., Onodera M., Abo H., Miyayama S., Gabata T., Matsui O. and Nakanuma Y. (2009a). IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am. J. Surg. Pathol. 33, 1886-1893.
192. Zen Y., Onodera M., Inoue D., Kitao A., Matsui O., Nohara T., Namiki M., Kasashima S., Kawashima A., Matsumoto Y., Katayanagi K., Murata T., Ishizawa S., Hosaka N., Kuriki K. and Nakanuma Y. (2009b). Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am. J. Surg. Pathol. 33, 1833-1839.
193. Zen Y. and Nakanuma Y. (2010). IgG4-related disease: a crosssectional study of 114 cases. Am. J. Surg. Pathol. 34,1812-1819.
194. Zen Y., Ishikawa A., Ogiso S., Heaton N. and Portmann B. (2012). Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology 60, 261-269.